TABLE 2

GAD, IA-2(256–760), and IA-2IC immunoreactivities in LADA and type 2 diabetic patients

Type 2 diabetes: analyzed in Rome, n = 1,020LADA: GADA+, n = 42 (4.1%)Type 2 diabetes: GADA−, n = 978 (95.9%)
IA-2ICA+13 (1.3)13 (30.9)0 (0)
IA-2(256–760)A+50 (4.9)*17 (40.5)33 (3.4)*
IA-2ICA+/IA-2(256–760)A+10 (1.0)10 (23.8)0 (0)
IA-2ICA+/IA-2(256–760)A−3 (0.3)3 (7.1)0 (0)
IA-2ICA−/IA-2(256–760)A+40 (3.9)7 (16.7)33 (3.4)
IA-2ICA−/IA-2(256–760)A−967 (94.8)22 (52.4)945 (96.6)

  • Data are n (%).

  • *

    * P < 0.0001 vs. IA-2ICA+.